Label: LEVOCETIRIZINE DIHYDROCHLORIDE tablet, coated

  • NDC Code(s): 43598-735-04, 43598-735-22, 43598-735-35, 43598-735-79, view more
    43598-735-80, 43598-735-95
  • Packager: Dr. Reddy's Laboratories Inc.
  • Category: HUMAN OTC DRUG LABEL
  • DEA Schedule: None
  • Marketing Status: Abbreviated New Drug Application

Drug Label Information

Updated March 19, 2024

If you are a consumer or patient please visit this version.

View All Sections
  • Active ingredient (in each tablet)

    Levocetirizine dihydrochloride USP, 5 mg

  • Purpose

    Antihistamine

  • Uses

    temporarily relieves these symptoms due to hay fever or other respiratory allergies:

    • runny nose
    • sneezing
    • itchy, watery eyes
    • itching of the nose or throat

  • Warnings

    Do not use

    • if you have kidney disease
    • if you have ever had an allergic reaction to this product or any of its ingredients or to an antihistamine containing cetirizine

    Ask a doctor before use if you have

    • ever had trouble urinating or emptying your bladder

    When using this product

    • drowsiness may occur
    • avoid alcoholic drinks
    • alcohol, sedatives, and tranquilizers may increase drowsiness
    • be careful when driving a motor vehicle or operating machinery 

    Stop use and ask doctor if

    • you have trouble urinating or emptying your bladder
    • an allergic reaction to this product occurs. Seek medical help right away.

    If pregnant or breast-feeding:

    • if breast-feding: not recommended
    • if pregnant: ask a health professional before use

    Keep out of reach of children.

    In case of overdose, get medical help or contact a Poison Control Center right away (1-800-222-1222).

  • Directions

    adults 65 years of age and older
    • ask a doctor
    adults and children 12-64 years of age
    • take 1 tablet (5 mg) once daily in the evening
    • do not take more than 1 tablet (5 mg) in 24 hours
    • 1/2 tablet (2.5 mg) once daily in the evening may be appropriate for less severe symptoms
    children 6-11 years of age
    • take 1/2 tablet (2.5 mg) once daily in the evening
    • do not take more than 1/2 tablet (2.5 mg) in 24 hours
    children under 6 years of age
    • do not use
    consumers with kidney disease
    • do not use

  • Other information

    • store between 20° and 25°C (68° and 77°F)
    • (bottles only) safety sealed: do not use if carton was opened or if printed foil inner seal on bottle is torn or missing
    • (blister only) safety sealed: do not use if seal is broken or if individual blister unit is open or torn

  • Inactive ingredients

    colloidal silicon dioxide, hypromellose, lactose monohydrate, magnesium stearate, microcrystalline cellulose, polyethylene glycol, titanium dioxide

  • Questions or comments?

    Call 1-888-375-3784

  • SPL UNCLASSIFIED SECTION

    Revised: 10/2022

  • Levocetirizine Dihydrochloride Tablets, USP 5 mg carton label

    Dr. Reddy's
    NDC 43598-735-35

    Original Prescription Strength

    Levocetirizine
    Dihydrochloride
    Tablets USP, 5 mg
    Antihistamine

    ALLERGY

    24 HOUR

    Relief of:

    • Sneezing
    • Runny Nose
    • Itchy Nose or Throat
    • Itchy, Watery Eyes

    35 Tablets

    carton735


  • Levocetirizine Dihydrochloride Tablets USP, 5 mg bottle label

    NDC 43598-735-35
    Dr.Reddy's

    Original Prescription Strength
    Levocetirizine
    Dihydrochloride Tablets USP, 5 mg
    Antihistamine

    ALLERGY

    24 HOUR

    35 Tablets

    bottle735

  • INGREDIENTS AND APPEARANCE
    LEVOCETIRIZINE DIHYDROCHLORIDE 
    levocetirizine dihydrochloride tablet, coated
    Product Information
    Product TypeHUMAN OTC DRUGItem Code (Source)NDC:43598-735
    Route of AdministrationORAL
    Active Ingredient/Active Moiety
    Ingredient NameBasis of StrengthStrength
    levocetirizine dihydrochloride (UNII: SOD6A38AGA) (levocetirizine - UNII:6U5EA9RT2O) levocetirizine dihydrochloride5 mg
    Inactive Ingredients
    Ingredient NameStrength
    CELLULOSE, MICROCRYSTALLINE (UNII: OP1R32D61U)  
    LACTOSE MONOHYDRATE (UNII: EWQ57Q8I5X)  
    SILICON DIOXIDE (UNII: ETJ7Z6XBU4)  
    MAGNESIUM STEARATE (UNII: 70097M6I30)  
    HYPROMELLOSES (UNII: 3NXW29V3WO)  
    TITANIUM DIOXIDE (UNII: 15FIX9V2JP)  
    Polyethylene Glycol, Unspecified (UNII: 3WJQ0SDW1A)  
    Product Characteristics
    ColorwhiteScore2 pieces
    ShapeOVALSize9mm
    FlavorImprint Code L
    Contains    
    Packaging
    #Item CodePackage DescriptionMarketing Start DateMarketing End Date
    1NDC:43598-735-351 in 1 CARTON03/12/2018
    135 in 1 BOTTLE; Type 0: Not a Combination Product
    2NDC:43598-735-221 in 1 CARTON03/12/2018
    255 in 1 BOTTLE; Type 0: Not a Combination Product
    3NDC:43598-735-801 in 1 CARTON03/12/2018
    380 in 1 BOTTLE; Type 0: Not a Combination Product
    4NDC:43598-735-792 in 1 CARTON04/17/2018
    45 in 1 BLISTER PACK; Type 0: Not a Combination Product
    5NDC:43598-735-041 in 1 CARTON02/15/2020
    5120 in 1 BOTTLE; Type 0: Not a Combination Product
    6NDC:43598-735-952 in 1 CARTON10/27/2023
    6200 in 1 BOTTLE; Type 0: Not a Combination Product
    Marketing Information
    Marketing CategoryApplication Number or Monograph CitationMarketing Start DateMarketing End Date
    ANDAANDA21037503/12/2018
    Labeler - Dr. Reddy's Laboratories Inc. (802315887)
    Establishment
    NameAddressID/FEIBusiness Operations
    Dr.Reddy's Laboratories Limited-FTO 3918608162analysis(43598-735) , manufacture(43598-735)
    Establishment
    NameAddressID/FEIBusiness Operations
    Reed-Lane, Inc.001819879pack(43598-735)
View All Sections

Find additional resources

(also available in the left menu)

Safety

Report Adverse Events, FDA Safety Recalls, Presence in Breast Milk

Related Resources

Medline Plus, Clinical Trials, PubMed, Biochemical Data Summary

More Info on this Drug

View Labeling Archives, RxNorm, Get Label RSS Feed, View NDC Code(s)NEW!